Table 1 Dosage and animal details of the control group and the treatment group included in the safety assessment of the concurrent use of fluralaner-moxidectin and praziquantel
Control group | Treatment group | ||
|---|---|---|---|
Fluralaner plus moxidectin treatment (study day) | – | 0 | |
Praziquantel treatment (study day) | 0 | 0 | |
Fluralaner dose (mg/kg body weight) | – | 93 | |
Moxidectin dose (mg/kg body weight) | – | 4.65 | |
Praziquantel dose (mg/kg body weight) | 16.7 | 16.7 | |
Sex | Male | 3 | 4 |
Female | 7 | 6 | |
Body weight pre-treatment (kg) | Mean ± SD | 3.7 ± 0.7 | 3.5 ± 0.6 |
Body weight at study end (kg) | Mean ± SD | 3.7 ± 0.7 | 3.6 ± 0.5 |